ALPHAZOL Trademark

Trademark Overview

On Friday, May 11, 2018, a trademark application was filed for ALPHAZOL with the United States Patent and Trademark Office. The USPTO has given the ALPHAZOL trademark a serial number of 87918138. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by Nexzol Pharma, Inc.. The ALPHAZOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and/or pharmaceutical formulations, for transdermal delivery, all for the treatments of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak
alphazol

General Information

Serial Number87918138
Word MarkALPHAZOL
Filing DateFriday, May 11, 2018
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6206132
Registration DateTuesday, November 24, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and/or pharmaceutical formulations, for transdermal delivery, all for the treatments of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 19, 2018
Primary Code005
First Use Anywhere DateTuesday, August 18, 2020
First Use In Commerce DateTuesday, August 18, 2020

Trademark Owner History

Party NameNexzol Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNexzol Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNexzol Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673

Trademark Events

Event DateEvent Description
Tuesday, May 15, 2018NEW APPLICATION ENTERED
Saturday, May 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 4, 2018ASSIGNED TO EXAMINER
Wednesday, September 5, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, September 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2019FINAL REFUSAL WRITTEN
Friday, March 8, 2019FINAL REFUSAL E-MAILED
Friday, March 8, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 8, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, March 8, 2019EXAMINERS AMENDMENT E-MAILED
Friday, March 8, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 8, 2019EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 29, 2019ASSIGNED TO LIE
Friday, March 29, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 12, 2019SOU TEAS EXTENSION RECEIVED
Thursday, December 12, 2019SOU EXTENSION 1 FILED
Thursday, December 12, 2019SOU EXTENSION 1 GRANTED
Saturday, December 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 3, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, August 3, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, August 18, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, August 18, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 18, 2020PETITION TO REVIVE-GRANTED
Tuesday, August 18, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 19, 2020NOTICE OF REVIVAL - E-MAILED
Wednesday, October 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 2, 2020SOU EXTENSION 2 FILED
Wednesday, October 7, 2020SOU EXTENSION 2 GRANTED
Tuesday, August 18, 2020USE AMENDMENT FILED
Wednesday, October 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 20, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Monday, November 24, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

alphazol infections pharmaceutical poison pain inflammation arthritis dermatitis fever joint blisters